Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;25(4):324-32.
doi: 10.1177/1533317510363468.

The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: A retrospective memory clinic study

Robert Laforce Jr  1 , James P Buteau, Nancy Paquet, Louis Verret, Michèle Houde, Rémi W Bouchard
Affiliations

The value of PET in mild cognitive impairment, typical and atypical/unclear dementias: A retrospective memory clinic study

Robert Laforce Jr et al. Am J Alzheimers Dis Other Demen. 2010 Jun.

Abstract

This retrospective study examined the role of [(18)F]fluorodeoxyglucose positron emission tomography (FDG-PET) in the diagnosis of atypical/unclear dementias in a memory clinic setting. A total of 94 patients with a diagnosis of mild cognitive impairment (MCI) or dementia, who had a PET study within 2 months of their diagnosis, were reevaluated at 5 and 18 months. Results showed that PET was associated with a change in diagnosis in 29% of patients and a 64% increase in the use of cholinesterase inhibitors (ChEIs). PET significantly lowered the number of atypical/unclear diagnoses from 39.4% to 16% and nearly 30% of these were found to have a typical Alzheimer's disease (AD) pattern of hypometabolism. In conclusion, the addition of PET to the investigation of atypical/unclear cases of dementia helped generating a more accurate diagnosis and initiating earlier treatment. PET was of limited contribution to typical AD and frontotemporal dementia (FTD) cases. This study provides guiding evidence about the true value of PET imaging in the day-to-day challenge of dementia diagnosis.

PubMed Disclaimer

References

    1. Herholz K., Carter SF, Jones M. Positron emission tomography imaging in dementia. Br J Radiol . 2007;80(2):160-167. - PubMed
    1. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging. 2005;32(4):486-510. - PubMed
    1. Mosconi L., Tsui WH, Herholz K., et al. Multicenter standardized FDG PET diagnosis of mild cognitive impairment, Alzheimer’s disease, and other dementias. J Nucl Med. 2008;49(3):390-398. - PMC - PubMed
    1. Pakrasi S., O’Brien JT Emission tomography in dementia. Nucl Med Commun. 2005;26(3):189-196. - PubMed
    1. Silverman DH , Small GW, Chang CY, et al. Positron emission tomography in evaluation of dementia: regional brain metabolism and long-term outcome. JAMA. 2001;286(17):2120-2127. - PubMed

Publication types

Substances